Àâòîðèçàöèÿ
Ïîèñê ïî óêàçàòåëÿì
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction
Îáñóäèòå êíèãó íà íàó÷íîì ôîðóìå
Íàøëè îïå÷àòêó? Âûäåëèòå åå ìûøêîé è íàæìèòå Ctrl+Enter
Íàçâàíèå: Signal Transduction
Àâòîðû: Gomperts B.D., Tatham P.E.R., Kramer I.M.
Àííîòàöèÿ: Signal Transduction is a text reference on cellular signalling processes. Starting with the basics, it explains how cells respond to external cues (hormones, cytokines, neurotransmitters, adhesion molecules, extracellular matrix, etc), and shows how these inputs are integrated and co-ordinated. The first half of the book provides the conceptual framework, explaining the formation and action of second messengers, particulary cyclic nucleotides and calcium, and the mediation of signal pathways by GTP-binding proteins. The remaining chapters deal with the formation of complex signalling cascades employed by cytokines and adhesion molecules, starting at the membrane and ending in the nucleus, there to regulate gene transcription. In this context, growth is an important potential outcome and this has relevance to the cellular transformations that underlie cancer. The book ends with a description at the molecular level of how signalling proteins interact with their environment and with each other through their structural domains. Each main topic is introduced with a historical essay, detailing the sources key observations and experiments that set the scence for recent and current work.
ßçûê:
Ðóáðèêà: Òåõíîëîãèÿ /
Ñòàòóñ ïðåäìåòíîãî óêàçàòåëÿ: Ãîòîâ óêàçàòåëü ñ íîìåðàìè ñòðàíèö
ed2k: ed2k stats
Ãîä èçäàíèÿ: 2002
Êîëè÷åñòâî ñòðàíèö: 424
Äîáàâëåíà â êàòàëîã: 21.12.2005
Îïåðàöèè: Ïîëîæèòü íà ïîëêó |
Ñêîïèðîâàòü ññûëêó äëÿ ôîðóìà | Ñêîïèðîâàòü ID
Ïðåäìåòíûé óêàçàòåëü
Hormones, receptor binding 25—26
HsEg5 238
Human immunodeficiency virus see “HIV”
Hyaluronan 324
ICAD (inhibitor of capsase activated DNAase) 336
ICAM (intercellular adhesion molecule) 285 318 319 349 351
ICAM-1 352
ICRAC 158 161
IgE-R (IgE high affinity receptor) 183
IgE-R, signalling pathways 288—289 289
IGF1 (insulin-like growth factor 1) see “Somatomedin 1”
IGF2 (insulin-like growth factor 2) see “Somatomedin 2”
IL-2 (interleukin-2) 213 285 288
IL-2 (interleukin-2) receptor 283
IL-3 (interleukin-3) 249
IL-6 (interleukin-6) 288 349
IL-8 (interleukin-8) 349
Immunoglobulin receptors 161 283
Immunoglobulin superfamily 318—319 378
Immunophilins 154 388 389
Immunoreceptor tyrosine-based activation motifs see “ITAMs”
InaC 207 208
InaD 207 208
Inflammation 23 345—349 346 347
Inflammation, eicosanoid actions 23
Inflammation, PKC 212—217
Inflammatory mediators 345 347 348
Inhibitor of capsase activated DNAase see “ICAD”
INK4 (inhibitor of cyclin-dependent kinase-4) 240 241 242
Inositol lipid cycle 179 180
Inositol-1, 4, 5-triphosphate see “IP3”
Insulin 3 19 20 22 299 310
Insulin receptor 4
Insulin receptor substrates see “IRS”
Insulin receptor, activation 259 262
Insulin receptor, PI 3-kinase activation 306 306
Insulin receptor, signalling 299—300
Insulin stimulated protein kinase see “ISPK”
Insulin, adenylyl cyclase activation 61
Insulin, glucose transport activation 307—308
Insulin, glycogen synthase activation 306—307 308
Insulin, insulin receptor interaction 28 306
Insulin, PKB activation 307
Insulin-derived growth factor see “IGF”
Insulin-like growth factor 1 (IGFl) see “Somatomedin 1”
Insulin-like growth factor 2 (IGF2) see “Somatomedin 2”
Insulin-stimulated protein kinase see “ISPK”
Integrins 249 317 318 319—320 319 320 325 328 329
Integrins, leukocyte trafficking 351 352—353
Intercellular adhesion molecule see “ICAM”
Interferon -receptor see “ -receptor”
Interferons 23 290—291
Interleukin-2 see “IL-2”
Interleukin-3 see “IL-3”
Interleukin-6 see “IL-6”
Interleukin-8 see “IL-8”
Interleukins 23
Intermediate filaments 331
Interphase 233
Intracellular (second) messengers 25
Inverse agonists 59 60 60 61 76 77
Ion channel-linked receptors 42—51
Ion channels, cyclic AMP regulation 197
Ion channels, cytosolic elevation 153
Ion channels, patch clamp studies 44—46 45
Ion channels, site-specific blocking 48
Ionomycin 150
IP3 (inositol-1, 4, 5-triphosphate) 25 120 122 216 261 265 285
IP3 receptor 154 155 756
IP3 receptor, calcium channel regulation 156 159 166 167 167 184
IP3 receptor, isoforms 155 156
IP3, intracellular mobilization 154—157 167
IRA (GTPase activating G-protein) 108
IRS (insulin receptor substrates) 306
IRS-1 306
Isoprenaline (isoproterenol) 35—36 37 62
ISPK (insulin stimulated protein kinase) 385
ITAMs (immunoreceptor tyrosine-based activation motifs) 286
JAK2 (Janus-kinase-2) 293 294 380—381
JNK (Jun N-terminal kinase) 210 272 274
JNK, apoptosis induction 327—328 328
JNK-1 (Jun N-terminal kinase-1) 209
Jun 208 209 265 271 272
Keratin 331—332
Kinases 25
Kinetochore 238 244 245
KIP/CIP 240 241—242
L-selectin 323 354
L-type channels 157
Lambda-PKC interaction protein see “LIP”
Lamin 238 337
Large T-antigen 243 250 251
LAT (linker for activation of T-cells) 287 290
LC20 238
Lck 285 286 376 377
Let-60 268
Leucine zipper 208
Leukaemia 225—226 226 293
Leukocyte common antigen see “CD45”
Leukocytes, adhesion/extravasion 345 352—353 354 354 355
Leukocytes, inflammatory response 212 345
Leukocytes, protection from apoptosis 326
Leukocytes, trafficking 345—355
Leukotriene LTB4 288
Leukotrienes 23
LFA-1 (lymphocyte function-associated antigen-1) 285 317 318
LH (luteinizing hormone) 20
LH receptors 194
Ligands, extracellular first messengers 19 20
Ligands, receptor interactions 14—16
Ligands, receptor interactions, binding 25—29
Linker for activation of T-cells see “LAT”
LIP (lambda-PKC interaction protein) 205
Lipid microdomains 290
LPA (lysophosphatidic acid) 204 205
LSD (lysergic acid diethylamide) 14
Luteinizing hormone see “LH”
Lymphocyte function-associated antigen-1 see “LFA-1”
Lymphotoxin 349
lyn 288 294
Lysergic acid diethylamide see “LSD”
Lysophosphatidic acid see “LPA”
M phase 233 see
M phase, checkpoint 234 244—245
Mac-1 215 316 318
MAD 365
Mad1 244
Mad2 244
MadCAM 319
Major histocompatibility complex see “MHC”
MAP kinase (mitogen activated protein kinase) 209 210 270—271 270
MAP kinase phosphatase-1 see “MKP-1”
MAP kinase, negative regulation 379—380 380
MAP kinase-ERK kinase see “MEK”
MAP kinase-integrating kinase-1 see “Mnkl”
MAP kinase-related proteins 273—275 274 275
MARCKS 200
Mast cells 23 158 212 288 289
Mastoparan 289
MEK (MAP kinase-ERK kinase) 271
MEK1 407
MEKK 350
Melanin 132
Metabotropic receptors 42 56—57
Metastasis 249 322
Metoprolol 36 37
MH1 365 370
MH2 365 370
MHC (Major histocompatibility complex) 283 285
Microfilaments 180
Middle T-antigen 257
Mitogen activated protein kinase see “MAP kinase”
Mitosis 233 238—240 239 see
MKP-1 (MAP kinase phosphatase-1) 379—380 380
MLCK (myosin light chain kinase) 184 275
Mnkl (MAP kinase-integrating kinase-1) 272 273
Monoclonal antibodies 316—317
Muscarine 39 40 41
Muscarinic receptors 39 40 42
Muscarinic receptors, acetylcholine interaction 40 55
Muscarinic receptors, antagonists 40 41
Muscarinic receptors, G-protein signalling 42 51 83—84
Muscarinic receptors, subtypes 40 41
Myc 271
myosin 182
Myosin II light chain see “LC20”
Myosin light chain kinase see “MLCK”
Mytl kinase 237 238
N-Ras 86
NAADP (nicotinic acid adenine dinucleotide Phosphate) 159 160—161 160
NADPH oxidase, respiratory burst 214—215 215 216
NCAM (neuronal cell adhesion molecule) 316 317 318 319
Nerve growth factor see “NGF”
Neurite outgrowth 315
Neurofibromatosis type 1 94
Neurofibromin 94 95
Neuromodulators 19
Neuromuscular junction, acetylcholine actions 38 40
Neuromuscular junction, nicotinic receptors 40 42—43 43
Neuromuscular junction, nicotinic receptors, subunits 44 45
Neuronal cell adhesion molecule see “NCAM”
Neuropeptides 24
Neurotransmitters 10—12 21 24
Neurotransmitters, signalling 181—182
Neurotransmitters, mutiple effects 19
Neutral antagonists 60
Neutrophils, antimicrobial defences 213 214
Neutrophils, antimicrobial defences, respiratory burst 213—215 275
Neutrophils, inflammatory response 213
NF- (nuclear factor ) 349 350 351
NF-AT 287 288 309 388 390
NFI 94
NGF (nerve growth factor) 227-230
Nicotine 15 16 39 41
Nicotinic acid adenine dinucleotide phosphate see “NAADP”
Nicotinic receptors 39 40
Nicotinic receptors, -bungarotoxin-mediated inactivation 43—44
Nicotinic receptors, acetylcholine interactions 38 49
Nicotinic receptors, antagonists 40 41
Nicotinic receptors, desensitization 49—50
Nicotinic receptors, electron microscopy 49 50
Nicotinic receptors, ion channel function 42—50
Nicotinic receptors, patch clamp studies 44—46 45
Nicotinic receptors, sarcolemma 182
Nicotinic receptors, subunits 44—45 45 51
Nicotinic receptors, subunits, membrane spanning sequences 47—49 48 49
Nicotinic receptors, subunits, sequence homologies 44—45 46 47
Nifedipine 157
NIK 350
Nitric oxide see “NO”
Nitric oxide synthase see “NOS”
NLS (nuclear localization sequence) 388
NMDA, glutamate receptor activation 158
NO (nitric oxide) 177 178
Non-receptor protein tyrosine kinase family 283-284 284 294 294
Noradrenaline (norepinephrine) 9 10 19 20 22 33 34
Noradrenaline, adenylyl cyclase activation 63
NOS (nitric oxide synthase) 177—178 309
Nuclear factor see “NF- ”
Nuclear localization sequence see “NLS”
Nucleolin 238
nucleotides 71
Occludin 331
Odorant substances, receptor interactions 54 197
Oestradiol 2
Okadaic acid 190 195 384
Olfactory cell ion channels 197
Oncogenes 208 292—294
Oncogenes, non-viral 293—294
Oncogenes, tyrosine kinase signal transduction components 293
Oncogenes, viral 292—293
Opiate receptors 99
Opiate receptors, homodimers 62
Opsin 61 127 139
Opsonization 215
Organophosphorus compounds 39 58
Organotherapy 5—8
Osteopontin 317
Oxytocin 20 24
Oxytocin receptor, progesterone actions 61 76
P-glycoproteins 112
P-selectin 323 351 354
P107 235 236
P130 235
P21-activated protein kinase see “PAK”
P38/HOG pathway 274
p53 242—243 249 250
P70 S6-kinase 307
PAK (p21-activated protein kinase) 337
PAR receptors (proteinase activated receptors) 58
Paracrine agents 19
Parathyroid -sensing receptors 56
Parathyroid hormone see “PTH”
Partial agonists 59
Patch clamp studies 42 44—46 45
PCNA (proliferating cell nuclear antigen) 241
PDGF (platelet derived growth factor) 22 249
PDGF receptor, activation 259 261 262 265 271
PDGF, historical aspects 230—231
PDGF, protein kinase B activation 307
PDKI (3-phosphoinositide dependent protein kinase-1) 305 310
Pdsl 238 245
PECAM 319
Pertussis toxin 80 116—119 118 197
PH (pleckstrin homology) domains 398—399 400 401
Phagocytosis 213 215
Phentolamine 63
Phenylephrine 36 37
Pheromone-induced mating response 96—100
Phorbol esters 199 201
Phorbol esters, inflammatory activity 212—215 213
Phorbol esters, tumour promoting activity 208
Phorbol myristate acetate see “PMA”
Phosphatases 25 175
Phosphatidylinositol see “PI”
Phosphatidylinositol 3-kinase see “PI 3-kinase”
Phosphatidylinositol 4, 5-bisphosphate see “PI(4 5)P2”
Phosphodiesterase, -calmodulin-sensitive 176—177
Phospholipase A2 see “PLA2”
Phospholipase C see “PLC”
Phospholipase D see “PLD”
Phospholipases 120—121 120
Phosphorylase 189 190 191 192 387
Phosphorylase kinase 175 191 275 386
Phosphorylation reactions 25 31 189—217
Phosphorylation reactions, byPKC 215—217
Phosphorylation reactions, adenylyl cyclase regulation 115 191
Phosphorylation reactions, cyclic AMP signal amplification 191—192
Phosphorylation reactions, glycogenosis 175
Phosphorylation reactions, protein kinase activity regulation 407 407
Phosphorylation reactions, protein kinase activity regulation, PKC 200 202 203
Phosphorylation reactions, receptor downregulation 49 50 84 85 85
Photoreceptors, cells 130—135
Photoreceptors, dark current 133 134
Photoreceptors, development in Drosophila 266—268 267 268
Photoreceptors, function 130—135
Photoreceptors, function, signal amplification 133
Photoreceptors, sensitivity 127—128 129
Phototransduction see “Visual transduction”
PI (phosphatidylinositol) 119 120 122 301
Ðåêëàìà